Latest Qiagen N.V. (QGEN) Headlines QIAGEN N.V.
Post# of 40
Posted On: 03/13/2014 1:40:23 AM
Latest Qiagen N.V. (QGEN) Headlines
QIAGEN N.V. Announces Successful Completion of Non-U.S. Offer Involving Convertible Notes
PR Newswire Europe - Wed Mar 12, 6:50PM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
QIAGEN N.V. Announces Successful Completion of
PR Newswire Europe - Wed Mar 12, 5:52PM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
QIAGEN N.V. Announces Terms of New Convertible Notes
PR Newswire Europe - Wed Mar 12, 10:39AM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
Dividend, Financial Results, Publishing of Clinical Study Data, New Offerings and Conference Call Schedules - Analyst Notes on H&R Block, Ulta Beauty, Myriad, QIAGEN, and Nutrisystem
PR Newswire - Wed Mar 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding H&R Block Inc. (NYSE: HRB), Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA), Myriad Genetics, Inc. (NASDAQ: MYGN), QIAGEN NV (NASDAQ: QGEN), and Nutrisystem Inc. (NASDAQ: NTRI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
QIAGEN N.V. Announces Non-U.S. Offer Involving Convertible Notes
PR Newswire Europe - Wed Mar 12, 3:18AM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
QIAGEN Expands GeneGlobe Web Portal to Include Interactive Access to Extensive Genomic Content from Ingenuity's Knowledge Base
PR Newswire - Tue Mar 11, 1:30AM CDT
-- GeneGlobe web portal now powered by QIAGEN's Ingenuity Target Explorer, linking assay search and selection tools with curated biological context
Concise Analysis of the International Genetic Testing Market
M2 - Fri Feb 28, 8:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/8z6k4n/global_genetic) has announced the addition of the "Concise Analysis of the International Genetic Testing Market" report to their offering. Currently, DTC genetic testing is the buzz word in the Global Genetic Testing market. DTC genetic testing refers to genetic tests that are marketed directly to consumers through television, print advertisements, or the internet. This form of testing, which is also called at-home genetic testing, provides access to a person's genetic information without the involvement of the consumer's healthcare provider. The DTC test typically includes collecting a DNA sample at home, often by swabbing the inside lining of the cheek, and mailing the sample back to the laboratory. Consumers are notified of their results by e-mail, over the phone, or the results are posted online on the websites of the offering companies. DTC genetic tests are expected to have a positive impact on the growth of the market during the forecast period. According to the report, one of the main drivers in this market is the increase in the aging population worldwide. The increasing prevalence of diseases such as diabetes, obesity, and cancer among the elderly population is contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the lack of a credible standard procedure to evaluate the analytic and clinical validity of genetic tests. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - Abbott Laboratories - Agilent Technologies Inc. - Clarient Inc. - Genomic Health Inc. - Hologenic Inc. - Myriad Genetics Inc. - Qiagen N.V. - Quest Diagnostics Inc. - Roche Holding AG - Sequenom Inc. - Transgenomic Inc. - bioM?rieux SA For more information visit http://www.researchandmarkets.com/research/8z...al_genetic
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
QIAGEN Launches careHPV(TM) Test in India to Expand Preventive Screening Against Cervical Cancer
PR Newswire - Wed Feb 26, 4:00AM CST
-- The careHPV(TM) Test is the first HPV diagnostic designed for regions with limited healthcare infrastructure, complementing QIAGEN's market-leading digene HC2 HPV Test
Biopreservation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 25, 5:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/t3jljp/biopreservation) has announced the addition of the "Biopreservation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of USD million. The report caters to market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and application markets. The global biopreservation market is categorized on the basis of product type, application and geography. The market estimates, from the period 2011 to 2019, for each of these segments is provided in USD million. The biopreservation market, by products is segmented into equipment, laboratory information management systems (LIMS) and media. The market for equipment is further analyzed as freezers, refrigerators, liquid nitrogen tanks and consumables. In addition, the media market is segmented into two types of formulations as home-brew media and pre-formulated media. The biopreservation market, by applications is segmented into regenerative medicine, biobanking and drug discovery. Geographically, the biopreservation market is estimated and analyzed with respect to four regions namely North America, Europe, Asia-Pacific and Rest of the World. Global trends such as drivers and restraints which impact the growth of the global biopreservation market are discussed in the market overview chapter of this report. In addition, the underlying opportunities for the market players are mentioned in this chapter. Scope of the Report Biopreservation Market, by Product Type - Equipment Freezers Refrigerators Liquid Nitrogen (LN2) Tanks Consumables - Laboratory Information Management Systems (LIMS) - Media -- Home-brew Media -- Pre-formulated Media Biopreservation Market, by Application - Regenerative Medicine - Biobanking - Drug Discovery Biopreservation Market, by Geography - North America - Europe - Asia-Pacific - Rest of the World Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Biopreservation Market Overview Chapter 4 Global Biopreservation Market, by Product Type Chapter 5 Global Biopreservation Market, by Applications Chapter 6 Global Biopreservation Market, by Geography Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles List of Figures List of Tables Companies Mentioned - BioCision, LLC - BioLife Solutions, Inc. - Biomatrica, Inc. - CHART MVE BIOMEDICAL - Dometic Group - LABVANTAGE Solutions, Inc. - Life Technologies Corporation - Panasonic Corporation - Qiagen N.V. - Thermo Fisher Scientific, Inc. - VWR International, LLC For more information visit http://www.researchandmarkets.com/research/t3...eservation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Hepatitis C treatment guidelines Markets to 2019 - Market Shares, Strategies, and Forecasts Report Available Online By ResearchMoz.us
PR Newswire - Wed Feb 19, 5:31AM CST
ResearchMoz.us includes new market research report "Hepatitis C Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports.
Demand Outlook for T&D Electrical Equipment Market in India - Transformer, Switchgear & Energy Meters
PR Newswire - Fri Feb 14, 11:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/77j8t4/demand_outlook) has announced the addition of the "Demand Outlook for T&D Electrical Equipment Market in India - Transformer, Switchgear & Energy Meters" report to their offering.
Qiagen to Simplify Next-Generation Sequencing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 5:00PM CST
Qiagen recently divulged its plans to launch innovative products.
Consumer Watchdog Asks FCC And DOJ To Block Comcast-Time Warner Deal; Merger Would Raise Cable TV Prices And Concentrate Power Over Broadband
PR Newswire - Thu Feb 13, 12:49PM CST
Consumer Watchdog is calling on the U.S. Justice Department and the Federal Communications Commission to block Comcast's deal to buy Time Warner Cable for $45 billion because it is anticompetitive and not in the public interest.
QIAGEN Announces Launches for Innovative Next-Generation Sequencing (NGS) Products to Generate Valuable Insights from any Sample
PR Newswire - Wed Feb 12, 1:00AM CST
-- Significant expansion of 'universal' portfolio compatible with any NGS system includes several novel sample preparation products as well as solutions for clinical use
QIAGEN Reports Fourth Quarter and Full-year 2013 Results
PR Newswire - Wed Jan 29, 3:00PM CST
-- Achieved 2013 targets: Adjusted net sales $1.31 billion (+5% CER), growth in all regions and customer classes; adjusted operating income $355.8 million; adjusted EPS $1.14 - Q4 2013 results: Adjusted net sales $362.6 million (+5% CER); adjusted operating income $106.3 million; adjusted EPS $0.36
QIAGEN N.V. Announces Successful Completion of Non-U.S. Offer Involving Convertible Notes
PR Newswire Europe - Wed Mar 12, 6:50PM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
QIAGEN N.V. Announces Successful Completion of
PR Newswire Europe - Wed Mar 12, 5:52PM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
QIAGEN N.V. Announces Terms of New Convertible Notes
PR Newswire Europe - Wed Mar 12, 10:39AM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
Dividend, Financial Results, Publishing of Clinical Study Data, New Offerings and Conference Call Schedules - Analyst Notes on H&R Block, Ulta Beauty, Myriad, QIAGEN, and Nutrisystem
PR Newswire - Wed Mar 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding H&R Block Inc. (NYSE: HRB), Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA), Myriad Genetics, Inc. (NASDAQ: MYGN), QIAGEN NV (NASDAQ: QGEN), and Nutrisystem Inc. (NASDAQ: NTRI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
QIAGEN N.V. Announces Non-U.S. Offer Involving Convertible Notes
PR Newswire Europe - Wed Mar 12, 3:18AM CDT
HILDEN, Germany, March 12, 2014 /PRNewswire/ --
QIAGEN Expands GeneGlobe Web Portal to Include Interactive Access to Extensive Genomic Content from Ingenuity's Knowledge Base
PR Newswire - Tue Mar 11, 1:30AM CDT
-- GeneGlobe web portal now powered by QIAGEN's Ingenuity Target Explorer, linking assay search and selection tools with curated biological context
Concise Analysis of the International Genetic Testing Market
M2 - Fri Feb 28, 8:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/8z6k4n/global_genetic) has announced the addition of the "Concise Analysis of the International Genetic Testing Market" report to their offering. Currently, DTC genetic testing is the buzz word in the Global Genetic Testing market. DTC genetic testing refers to genetic tests that are marketed directly to consumers through television, print advertisements, or the internet. This form of testing, which is also called at-home genetic testing, provides access to a person's genetic information without the involvement of the consumer's healthcare provider. The DTC test typically includes collecting a DNA sample at home, often by swabbing the inside lining of the cheek, and mailing the sample back to the laboratory. Consumers are notified of their results by e-mail, over the phone, or the results are posted online on the websites of the offering companies. DTC genetic tests are expected to have a positive impact on the growth of the market during the forecast period. According to the report, one of the main drivers in this market is the increase in the aging population worldwide. The increasing prevalence of diseases such as diabetes, obesity, and cancer among the elderly population is contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the lack of a credible standard procedure to evaluate the analytic and clinical validity of genetic tests. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - Abbott Laboratories - Agilent Technologies Inc. - Clarient Inc. - Genomic Health Inc. - Hologenic Inc. - Myriad Genetics Inc. - Qiagen N.V. - Quest Diagnostics Inc. - Roche Holding AG - Sequenom Inc. - Transgenomic Inc. - bioM?rieux SA For more information visit http://www.researchandmarkets.com/research/8z...al_genetic
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
QIAGEN Launches careHPV(TM) Test in India to Expand Preventive Screening Against Cervical Cancer
PR Newswire - Wed Feb 26, 4:00AM CST
-- The careHPV(TM) Test is the first HPV diagnostic designed for regions with limited healthcare infrastructure, complementing QIAGEN's market-leading digene HC2 HPV Test
Biopreservation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 25, 5:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/t3jljp/biopreservation) has announced the addition of the "Biopreservation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of USD million. The report caters to market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and application markets. The global biopreservation market is categorized on the basis of product type, application and geography. The market estimates, from the period 2011 to 2019, for each of these segments is provided in USD million. The biopreservation market, by products is segmented into equipment, laboratory information management systems (LIMS) and media. The market for equipment is further analyzed as freezers, refrigerators, liquid nitrogen tanks and consumables. In addition, the media market is segmented into two types of formulations as home-brew media and pre-formulated media. The biopreservation market, by applications is segmented into regenerative medicine, biobanking and drug discovery. Geographically, the biopreservation market is estimated and analyzed with respect to four regions namely North America, Europe, Asia-Pacific and Rest of the World. Global trends such as drivers and restraints which impact the growth of the global biopreservation market are discussed in the market overview chapter of this report. In addition, the underlying opportunities for the market players are mentioned in this chapter. Scope of the Report Biopreservation Market, by Product Type - Equipment Freezers Refrigerators Liquid Nitrogen (LN2) Tanks Consumables - Laboratory Information Management Systems (LIMS) - Media -- Home-brew Media -- Pre-formulated Media Biopreservation Market, by Application - Regenerative Medicine - Biobanking - Drug Discovery Biopreservation Market, by Geography - North America - Europe - Asia-Pacific - Rest of the World Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Biopreservation Market Overview Chapter 4 Global Biopreservation Market, by Product Type Chapter 5 Global Biopreservation Market, by Applications Chapter 6 Global Biopreservation Market, by Geography Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles List of Figures List of Tables Companies Mentioned - BioCision, LLC - BioLife Solutions, Inc. - Biomatrica, Inc. - CHART MVE BIOMEDICAL - Dometic Group - LABVANTAGE Solutions, Inc. - Life Technologies Corporation - Panasonic Corporation - Qiagen N.V. - Thermo Fisher Scientific, Inc. - VWR International, LLC For more information visit http://www.researchandmarkets.com/research/t3...eservation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Hepatitis C treatment guidelines Markets to 2019 - Market Shares, Strategies, and Forecasts Report Available Online By ResearchMoz.us
PR Newswire - Wed Feb 19, 5:31AM CST
ResearchMoz.us includes new market research report "Hepatitis C Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports.
Demand Outlook for T&D Electrical Equipment Market in India - Transformer, Switchgear & Energy Meters
PR Newswire - Fri Feb 14, 11:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/77j8t4/demand_outlook) has announced the addition of the "Demand Outlook for T&D Electrical Equipment Market in India - Transformer, Switchgear & Energy Meters" report to their offering.
Qiagen to Simplify Next-Generation Sequencing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 5:00PM CST
Qiagen recently divulged its plans to launch innovative products.
Consumer Watchdog Asks FCC And DOJ To Block Comcast-Time Warner Deal; Merger Would Raise Cable TV Prices And Concentrate Power Over Broadband
PR Newswire - Thu Feb 13, 12:49PM CST
Consumer Watchdog is calling on the U.S. Justice Department and the Federal Communications Commission to block Comcast's deal to buy Time Warner Cable for $45 billion because it is anticompetitive and not in the public interest.
QIAGEN Announces Launches for Innovative Next-Generation Sequencing (NGS) Products to Generate Valuable Insights from any Sample
PR Newswire - Wed Feb 12, 1:00AM CST
-- Significant expansion of 'universal' portfolio compatible with any NGS system includes several novel sample preparation products as well as solutions for clinical use
QIAGEN Reports Fourth Quarter and Full-year 2013 Results
PR Newswire - Wed Jan 29, 3:00PM CST
-- Achieved 2013 targets: Adjusted net sales $1.31 billion (+5% CER), growth in all regions and customer classes; adjusted operating income $355.8 million; adjusted EPS $1.14 - Q4 2013 results: Adjusted net sales $362.6 million (+5% CER); adjusted operating income $106.3 million; adjusted EPS $0.36
(0)
(0)Qiagen N.V. (QGEN) Stock Research Links
Scroll down for more posts ▼